
Sign up to save your podcasts
Or


Andrew Chanin, CEO of ProcureAM, discusses space investing after the Blue Origin flight, and the Procure Space ETF (UFO). Paul Christopher, Head of Global Market Strategy for the Wells Fargo Investment Institute, discusses markets, and how long growth has to run. Adam Johnson, author of Bullseye Brief, discusses earnings, and opportunities in equities. Sam Fazeli, Bloomberg Intelligence Senior Pharmaceutical Analyst, discusses the highly transmissible delta variant and the potential for a new Covid vaccine. Hosted by Matt Miller and Paul Sweeney.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
Andrew Chanin, CEO of ProcureAM, discusses space investing after the Blue Origin flight, and the Procure Space ETF (UFO). Paul Christopher, Head of Global Market Strategy for the Wells Fargo Investment Institute, discusses markets, and how long growth has to run. Adam Johnson, author of Bullseye Brief, discusses earnings, and opportunities in equities. Sam Fazeli, Bloomberg Intelligence Senior Pharmaceutical Analyst, discusses the highly transmissible delta variant and the potential for a new Covid vaccine. Hosted by Matt Miller and Paul Sweeney.
See omnystudio.com/listener for privacy information.

976 Listeners

1,167 Listeners

2,184 Listeners

423 Listeners

971 Listeners

196 Listeners

1,037 Listeners

188 Listeners

69 Listeners

1,308 Listeners

65 Listeners

78 Listeners

30 Listeners

60 Listeners

5 Listeners

58 Listeners

233 Listeners

232 Listeners

67 Listeners

83 Listeners

77 Listeners

76 Listeners

87 Listeners

399 Listeners

18 Listeners

13 Listeners

7 Listeners

2 Listeners

115 Listeners

23 Listeners